Provider review
MaxLife review
MaxLife itself has a real FDA warning letter (February 2026).
MaxLife (maxlife.com) received its own FDA warning letter — MaxLife Technologies Inc. dba Maxlife, MARCS-CMS 721453, February 20, 2026 — for a mislabeled-compounder template and misleading FDA-approval claims, the same mass-enforcement wave already documented for several peers on this roster. Separately, its own /semaglutide page discloses its homepage's "Starting at $155/mo" headline is a first-month rate; the true standing price is $195/mo, 26% higher.
Transparency scorecard
2 of 4 disclosed openly
What MaxLife discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
MaxLife's own homepage states "Starting at $155/mo" (semaglutide) and "Starting at $195/mo" (tirzepatide). Its dedicated /semaglutide page discloses "$155/First month Then $195/mo" for the Monthly Plan, plus a Quarterly Plan billing "$465 for 3 months." Its dedicated /tirzepatide page states a flat "$195/mo" with no promo found.
What you actually pay, month to month
$195/month is the confirmed standing ("Then") price for semaglutide after the first month, and the flat, no-promo price for tirzepatide from the first order — read directly off each product's own dedicated page.
The commitment trap
The homepage's "Starting at $155/mo" semaglutide headline is reached only via a first-month promotional rate or a 3-month prepay ("$465 for 3 months") — never as an ongoing no-commitment monthly rate, which is $195/mo. Tirzepatide has no equivalent gap.
Checked live on MaxLife's own site at https://maxlife.com/semaglutide in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off MaxLife's own public pages on the date shown, not from a third-party comparison table.
The bottom line
MaxLife (maxlife.com, legal entity Maxlife Technologies Inc., Irvine, CA) is a real, live telehealth company selling compounded tirzepatide (flat $195/mo, no promo found) and compounded semaglutide (a $155/mo first-month rate that reverts to $195/mo), naming three fulfillment pharmacies directly on its homepage. Two real, independent findings: MaxLife's own FDA warning letter from the February 2026 mass-enforcement wave, and a confirmed promo-to-standing gap on its semaglutide pricing specifically (tirzepatide has no equivalent gap).
MaxLife appears on our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You've read MaxLife's own FDA warning letter and are comfortable with the same mislabeled-compounder finding already disclosed for several peers on this roster.
- You want tirzepatide's true, flat, no-promo standing price up front — $195/mo, confirmed directly.
- You want three fulfillment pharmacies named directly, even though none is tied to a 503A/503B category.
Look elsewhere if
- You're budgeting around the homepage's "Starting at $155/mo" semaglutide headline — the true standing price is $195/mo, confirmed on MaxLife's own dedicated page.
- You want every named pharmacy partner free of any FDA regulatory history — Strive Pharmacy has a real warning letter (2022/2023) already documented for two other providers on this roster.
- You want to cancel without notice — MaxLife's own FAQ requires "a cancellation notice at least 30 days before your next billing period begins."
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what MaxLife bundles in, and what it does not.
Clinician consult
Included
— MaxLife describes a licensed-provider review before any prescription is issued.
Bloodwork / labs
Not stated on the pages checked.
Follow-ups and dose changes
Not itemized on the pages checked.
Human support
No dietitian, nurse, or structured coaching program is named…
anywhere on the pages checked.
Injection supplies
Not itemized beyond the medication itself on the pages checked.
Shipping
Not itemized on the pages checked.
Who fills it, and who's watching
The pharmacy
Unknown. Its own homepage names three fulfillment pharmacies directly, "Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy," but ties none of them to a 503A/503B category anywhere checked.
Oversight
Included — MaxLife describes a licensed-provider review before any prescription is issued. Not itemized on the pages checked.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
All states. Its own homepage states plainly, "Maxlife.com provides services in all states across the United States."
The honest cons
The part they would rather you skipped
MaxLife itself — not just a named partner — has a real, current FDA warning letter, independently confirmed directly at its own fda.gov page: MaxLife Technologies Inc. dba Maxlife, MARCS-CMS 721453, February 20, 2026, citing a mislabeled-compounder template ("identifies '[name]' on the pictured label, suggesting [name] is the compounder when in fact it is not") plus misleading FDA-approval claims — the identical February 20, 2026 mass-enforcement wave already documented for Strut Health, MEDVi, 24HrDoc, Ivim, Viv, BluefitMD, Kin Meds, Join Josie, and Momentum Health 360 elsewhere on this roster, not a distinct or unusual action. Per the standing rule already applied to those peers, this alone does not disqualify MaxLife; a targeted search for independent journalism documenting fabricated physician personas or deepfaked patient photos (the MEDVi-class disqualifier) came back empty. Separately, one of its three named pharmacies, Strive Pharmacy, carries its own separate FDA warning letter (2022/2023) — the same finding already made for Bionomy Health and Care Bare Rx elsewhere on this roster. Also separately, its own homepage "Starting at $155/mo" semaglutide headline is a first-month/3-month-prepay rate; the true standing price is $195/mo, 26% higher.
- MaxLife itself has a real FDA warning letter (February 2026) for a mislabeled-compounder template and misleading FDA-approval claims.
- Its own "Starting at $155/mo" semaglutide headline is a promo/prepay rate — the true standing price is $195/mo.
- One of its three named pharmacies, Strive Pharmacy, has its own separate FDA warning letter.
None of this is unique to MaxLife — the whole category shares it.
How it compares
The providers we rank on our semaglutide provider ranking — the most specific board MaxLife sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- CBCare Bare RxNames both compounds directly — but two of its four pharmacies carry FDA letters.
- TRTelos RxA specific, sourced state-exclusion list — next to an unconfirmed "compare" price.
- BMBreeze MedsNames the specific compound in its own nav menu — pricing is quiz-gated.
- TRTrimiNames two 503A pharmacies directly, undercut by an annual-prepay headline.
- OAOakA flat, no-subscription price — but no pharmacy is named anywhere on the site.
- Strut HealthAn FDA warning letter over labeling, plus an auto-refill price on every product.
- MAMangoRxA flat, "price locked in" semaglutide product — its pharmacy is described, not named.
- GHGala HealthAdvertises the same $179 promo price for two different drugs.
77 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect MaxLife's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MaxLife's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.